Skip to main content
. 2024 Feb 29;13(3):216. doi: 10.3390/pathogens13030216

Table 1.

Characteristics of patients.

Patient Characteristics SARS-CoV-2 Undetected
(n = 57)
SARS-CoV-2 Detected
(n = 59)
Age 60.2 (15~91) 70.7 (31~91)
Gender [Number (%)]
Male
Female

38 (66.7)
19 (33.3)

48 (81.4)
11 (18.6)
Outcomes [Number (%)]
Died
Discharged
Transferred
Undischarged
NA

5 (8.8)
36 (63.1)
8 (14.0)
3 (5.3)
5 (8.8)

14 (23.7)
27 (45.8)
13 (22.0)
4 (6.8)
1 (1.7)
Severity [Number (%)]
ICU
UnICU

17 (29.8)
40 (70.2)

32 (54.2)
27 (45.8)
Symptoms [Number (%)]
Chest.Pain
Cough
Cough up Phlegm (CuP)
Diarrhoea
Fever
Loss of Appetite (LoA)
Vomiting

9 (15.8)
42 (73.7)
36 (63.2)
7 (12.3)
38 (66.7)
15 (26.3)
8 (14.0)

10 (16.9)
53 (89.8)
51 (86.4)
18 (30.5)
48 (81.4)
26 (44.1)
9 (15.3)
Comorbidities [Number (%)]
Coronary Artery Disease (CAD)
Chronic Lung Disease (CLD)
Diabetes
Hyperlipidemia
Hypertension
Other infectious disease (OID)
Tumor

16 (28.1)
4 (7.0)
14 (24.6)
0 (0)
18 (31.6)
4 (7.0)
10 (17.5)

31 (52.5)
7 (11.9)
16 (21.7)
1 (1.7)
32 (54.2)
4 (6.8)
14 (23.7)
Treatment [Number (%)]
Antibiotic therapy (ABT)
Antiviral therapy (AVT)
ECMO
Hormone therapy (HormT)
Immunoglobulin therapy (IgT)
Invasive ventilation (IV)
Non-Invasive ventilation (NIV)

44 (77.2)
11 (19.3)
1 (1.75)
20 (35.09)
8 (14.04)
13 (22.81)
15 (26.32)

50 (84.7)
49 (83.1)
0 (0)
42 (71.2)
18 (30.5)
39 (66.1)
23 (40.0)